CHANDRA MARLIN: Open Payments
NPI 1881237808 · COLUMBUS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$265 in 12 payments from 8 companies in 2025. Trend: 2023 $591 · 2024 $597 · 2025 $265
Food & beverage: $265
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 3 | $65 |
| Calyxo, Inc. | 2 | $46 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $36 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $28 |
| 180 Medical, Inc. | 1 | $26 |
| Astellas Pharma US Inc | 1 | $24 |
| UROGEN PHARMA, INC. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
Products named: ORGOVYX, CVAC ASPIRATION SYSTEM, JOURNAVX, PYLARIFY, Xtandi, Nubeqa, GEMTESA.
Industry payments across IN — which companies pay providers there.
